UK pharma giant to ensure U.S. and Europe get drugs made outside China while China gets drugs made at home

The British drugmaker is acquiring Gracell Biotechnologies, building on a run of deals in China, mostly licensing agreements rather than purchases

British pharma giant to make $1 billion up-front cash payment for Shanghai-based Gracell

Conglomerate Astra and Singapore’s Temasek among first-time investors

The vaccine stopped an average of 70% of participants from falling ill, an early analysis of the data show